Cited by 5Pharmaceutical Quality and CounterfeitingPharmaceutical Economics and PolicyIdentification and Quantification in Food

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Anti-Counterfeit Technologies for Spurious Drugs in India

Dass, Ruchi, Gajjar, Bharat·2011·International Journal of User-Driven Healthcare

Abstract

The problem of counterfeit drugs in India has led to significant negative publicity around the world. In this paper, the author discusses how mobile/radio based and other technologies are not only helping educate people on how to check counterfeit medicines and supply chain management, but also promoting disease surveillance and spurious drugs data collection.

Overview

Integrity signals

Registry

Crossref · 10.4018/ijudh.2011100104

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 2

  1. India's Fake Drugs Are a Real Problem, Roger Bate, Legatum Institute and the International Policy Network report. (2010). Wall Street Journal. Retrieved from http://www.fightingmalaria.org/article.aspx?id=1442
  2. I.Pharmaceuticals, 2010, Healthcare Report

Cited by

Sorted by citations

See all 5

Metadata

Authors
Dass, R., & Gajjar, B.
Affiliations
  • Commonwealth Connect Program and HealthCursor, India
  • Pramukhswami Medical College (IN)
Venue
International Journal of User-Driven Healthcare
Published
2011-10-01
Volume
1
Issue
4
Pages
42-52
ISSN
  • 2156-180X (ISSN-L)
  • 2156-1818
OpenAlex
W2043071968
Cited by
5
References
3
Citations by year
2024: 1 · 2022: 1 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
0.94
Type
journal article
Language
ng
Open access
closed
Locations
  • International Journal of User-Driven Healthcare (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Identification and Quantification in Food
Keywords
counterfeit drugs, anti-counterfeiting technology, mobile health, pharmaceutical supply chain, disease surveillance, India

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-Counterfeit Technologies for Spurious Drugs in India. https://app.cochat.ai/papers/10.4018/ijudh.2011100104
The paper
Dass, R., & Gajjar, B. (2011). Anti-Counterfeit Technologies for Spurious Drugs in India. International Journal of User-Driven Healthcare. https://doi.org/10.4018/ijudh.2011100104